Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News enVVeno Medical Corp NVNO

enVVeno Medical Corporation is a late-stage clinical med-tech company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe Chronic Venous Insufficiency (CVI) of the deep venous system... see more

Recent & Breaking News (NDAQ:NVNO)

Hancock Jaffe Announces One Year Follow-up Data on Two Additional VenoValve Patients

Accesswire August 21, 2020

Hancock Jaffe Regains Compliance with Nasdaq Stockholder's Equity Rule

Accesswire August 10, 2020

Hancock Jaffe Receives Permission to Proceed with First-in-Human CoreoGraft Study

Accesswire July 23, 2020

Hancock Jaffe Laboratories Announces Closings of $6.2 Million Offerings Including Full Exercise of Over-Allotment Option

Accesswire July 21, 2020

Hancock Jaffe Laboratories Announces Pricing of $5.6 Million Offering

Accesswire July 17, 2020

Hancock Jaffe Announces Registered Direct Offering Priced At Market

Accesswire June 1, 2020

Hancock Jaffe Announces Intention to Merge with Catheter Precision

Accesswire June 1, 2020

Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study

Accesswire May 12, 2020

Hancock Jaffe Announces One Year Follow-up Data on VenoValve Patients

Accesswire April 28, 2020

Hancock Jaffe Announces Registered Direct Offering

Accesswire April 27, 2020

Principal Investigator Dr. Jorge Hernando Ulloa Presents Updated VenoValve Data at the 32nd Annual Meeting of the American Venous Forum

Accesswire March 5, 2020

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present Updated VenoValve Data Next Week at the 32nd Annual Meeting of the American Venous Forum

Accesswire February 26, 2020

Hancock Jaffe Reports Positive Results for 6 Month CoreoGraft Animal Feasibility Study

Accesswire January 8, 2020

VenoValve Abstract Published in January 2020 Edition of Journal of Vascular Surgery

Accesswire December 20, 2019

Hancock Jaffe Medical Team to Make Presentations at 46th Annual VEITH Vascular Symposium November 19 to November 23 in New York City

Accesswire November 19, 2019

Hancock Jaffe Enrolls and Successfully Implants Tenth VenoValve Patient

Accesswire November 15, 2019

Principal Investigator Dr. Jorge Hernando Ulloa Presents 6 Month VenoValve Data at the 20th Congress of Asian Society for Vascular Surgery

Accesswire October 24, 2019

Principal Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Six Month Data at the 20th Congress of Asian Society for Vascular Surgery on October 25, 2019

Accesswire October 22, 2019

Hancock Jaffe to Present at the Inaugural MicroCap Rodeo Investor Conference on October 16, 2019

Accesswire October 14, 2019

Hancock Jaffe to Host Virtual Roadshow Webinar on Thursday, October 3, 2019 at 4:30 p.m. Eastern Time

Accesswire September 26, 2019